Inogen (INGN) Income from Continuing Operations (2013 - 2026)
Inogen (INGN) reported Income from Continuing Operations of 8324000.0 for Q1 2026, down 34.82% year-over-year from 12771465.21 in Q1 2025, and down 1.95% quarter-over-quarter from 8165000.0 in Q4 2025.
Inogen (INGN) Income from Continuing Operations (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Income from Continuing Operations data on file, last reported at 8324000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 8324000.0, down 34.82% year-over-year; the trailing twelve-month figure through Mar 2026 was 25935000.0 (down 22.56% YoY), and the FY2025 annual result was 23785000.0, up 19.55% from the prior year.
- Income from Continuing Operations fell to 8324000.0 in Q1 2026 per INGN's latest filing, from 8165000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 27812000.0 in Q4 2022 and troughed at 45719000.0 in Q3 2023.
- A 5-year average of 9630823.53 and a median of 8165000.0 in 2025 frame the typical range for Income from Continuing Operations.
- On a YoY basis, Income from Continuing Operations climbed as much as 273.36% in 2022 and fell as far as 1841.8% in 2022.
- A 5-year view of Income from Continuing Operations shows it stood at 27812000.0 in 2022, then sank by 196.38% to 26806000.0 in 2023, then soared by 87.19% to 3434000.0 in 2024, then slumped by 137.77% to 8165000.0 in 2025, then declined by 1.95% to 8324000.0 in 2026.
- Business Quant data shows INGN's Income from Continuing Operations at 8324000.0 in Q1 2026, 8165000.0 in Q4 2025, and 5294000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | -8.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.32 Mn |
| Dec 31, 2025 | -8.17 Mn |
| Sep 30, 2025 | -5.29 Mn |
| Jun 30, 2025 | -4.15 Mn |
| Mar 31, 2025 | -6.17 Mn |
| Dec 31, 2024 | -3.43 Mn |
| Sep 30, 2024 | -5.96 Mn |
| Jun 30, 2024 | -5.59 Mn |
| Mar 31, 2024 | -14.58 Mn |
| Dec 31, 2023 | -26.81 Mn |
| Sep 30, 2023 | -45.72 Mn |
| Jun 30, 2023 | -9.83 Mn |
| Mar 31, 2023 | -20.35 Mn |
| Dec 31, 2022 | 27.81 Mn |
| Sep 30, 2022 | -9.51 Mn |
| Jun 30, 2022 | -3.44 Mn |
| Mar 31, 2022 | -14.21 Mn |
| Dec 31, 2021 | -16.04 Mn |
| Sep 30, 2021 | 12.17 Mn |
| Jun 30, 2021 | 5.10 Mn |